Home / insider
Pauwels Eric
CHIEF BUSINESS OFFICER
Mr. Pauwels has served as our Chief Business Officer since April 2020. Mr. Pauwels has 40 years of healthcare experience in biopharmaceuticals and medical devices. Mr. Pauwels joined the Company in March 2015 as Senior Vice President and General Manager of the Americas. He also serves as a director of one of our subsidiaries. From September 2011 until March 2015, Mr. Pauwels was the Chief Commercial Officer and President of International for NPS Pharmaceuticals, a publicly traded biopharmaceutical company that was acquired by Shire plc. In 2011, Mr. Pauwels was the Chief Marketing Officer of Accuray Inc. From 2005 to 2010 Mr. Pauwels served as the first Chief Commercial Officer for Shire Human Genetic…
Biography from the company’s latest DEF 14A proxy statement
PTCT price and prints
Full PTCT chartPTC THERAPEUTICS, INC. 71 open-market prints by this insider, 11/3/2020 – 6/10/2026. Triangles mark only their Form 4 purchases and sales.
PTCT trades
| Date | Form 4 | Ticker | Side | Shares | Value | 90d | 180d |
|---|---|---|---|---|---|---|---|
| 6/10/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 3,711 | $278.3K | +6.19% | +3.74%hist |
| 6/10/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 17,566 | $1.32M | +6.19% | +3.74%hist |
| 2/18/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 3,019 | $209.4K | −2.00% | −5.73% |
| 1/12/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,024 | $80.6K | +9.24% | −4.82% |
| 1/9/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,722 | $133.3K | +8.62% | −14.2% |
| 1/8/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 587 | $45.2K | +7.27% | −16.1% |
| 1/8/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,454 | $111.2K | +7.27% | −16.1% |
| 1/8/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 2,561 | $195.7K | +7.27% | −16.1% |
| 1/7/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,352 | $104.8K | +9.92% | −10.6% |
| 1/6/2026 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,789 | $137.7K | +10.2% | −11.4% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,500 | $113.7K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 59 | $4.6K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 313 | $24.3K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 59 | $4.6K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 42 | $3.2K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 37 | $2.8K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 4,537 | $346.3K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 10,548 | $818.0K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 3,220 | $252.2K | +14.6% | +0.05% |
| 12/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 193 | $14.6K | +14.6% | +0.05% |
| 12/18/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 251 | $18.8K | +10.2% | +1.77% |
| 12/18/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 120 | $9.0K | +10.2% | +1.77% |
| 12/18/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 2,831 | $212.5K | +10.2% | +1.77% |
| 12/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 35,261 | $2.66M | +9.99% | −2.44% |
| 12/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 100 | $7.6K | +9.99% | −2.44% |
| 12/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 100 | $7.6K | +9.99% | −2.44% |
| 12/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 3,584 | $269.9K | +9.99% | −2.44% |
| 12/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,245 | $93.7K | +9.99% | −2.44% |
| 9/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 16,698 | $950.8K | −35.0% | −20.1% |
| 9/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 6,017 | $342.4K | −35.0% | −20.1% |
| 9/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 8,528 | $485.4K | −35.0% | −20.1% |
| 9/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 3,713 | $211.3K | −35.0% | −20.1% |
| 9/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 2,406 | $136.9K | −35.0% | −20.1% |
| 9/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,238 | $70.4K | −35.0% | −20.1% |
| 9/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,250 | $71.1K | −35.0% | −20.1% |
| 3/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 3,340 | $192.6K | +9.27% | −3.17% |
| 3/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 300 | $17.5K | +9.27% | −3.17% |
| 3/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 2,037 | $112.5K | +9.27% | −3.17% |
| 3/17/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,085 | $61.4K | +9.27% | −3.17% |
| 3/14/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 4,458 | $246.0K | +6.46% | −7.03% |
| 2/20/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,567 | $78.5K | +8.28% | +1.57% |
| 2/19/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,378 | $69.0K | +6.40% | +1.24% |
| 1/8/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 2,136 | $95.1K | +11.7% | −6.53% |
| 1/7/2025 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,599 | $72.5K | +4.01% | −7.55% |
| 4/17/2024 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 787 | $19.8K | −35.8% | −55.6% | |
| 1/30/2024 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 366 | $10.0K | −21.0% | −22.4% |
| 1/9/2024 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 2,065 | $59.9K | +6.37% | −10.5% |
| 1/8/2024 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,569 | $44.9K | +10.4% | −5.80% |
| 5/22/2023 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 1,913 | $112.8K | +32.7% | +62.5% |
| 5/22/2023 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 100 | $6.0K | +32.7% | +62.5% |
| 5/19/2023 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 6,403 | $377.5K | +31.5% | +64.4% |
| 5/18/2023 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 788 | $46.3K | +30.6% | +65.0% |
| 5/17/2023 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 7,248 | $424.0K | +29.2% | +68.2% |
| 5/17/2023 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 800 | $46.8K | +29.2% | +68.2% |
| 4/18/2023 | Form 410b5-1 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 732 | $38.1K | +27.0% | +62.2% |
| 1/31/2023 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 375 | $17.1K | −20.2% | +12.1% | |
| 1/24/2023 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 359 | $17.0K | −11.8% | +18.2% | |
| 1/11/2023 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 571 | $25.3K | −6.10% | +11.9% | |
| 1/10/2023 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 663 | $28.5K | −9.63% | +9.22% | |
| 1/9/2023 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 858 | $35.7K | −16.9% | +3.20% | |
| 4/19/2022 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 822 | $35.0K | +0.28% | −25.9% | |
| 2/1/2022 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 367 | $14.7K | +10.7% | −10.7% | |
| 1/25/2022 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 359 | $14.1K | −2.55% | −10.5% | |
| 1/7/2022 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 866 | $33.4K | −12.9% | −12.6% | |
| 1/4/2022 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 806 | $33.2K | −5.87% | −7.02% | |
| 4/19/2021 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 786 | $37.9K | +11.9% | +21.4% | |
| 2/1/2021 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 362 | $20.6K | +28.2% | +31.9% | |
| 1/25/2021 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 431 | $26.7K | +26.6% | +36.8% | |
| 1/5/2021 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 778 | $48.5K | +23.8% | +33.1% | |
| 1/5/2021 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 289 | $18.0K | +23.8% | +33.1% | |
| 11/3/2020 | PTC THERAPEUTICS, INC · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$14.15BPrice$65.3752w high$89.5552w low$57.84 | SELL | 6,194 | $350.0K | +0.14% | +28.3% |
Chart uses split-adjusted closes from the first print through the latest available bar. Returns use the last close on or before the trade date and the first close on or after 90 and 180 calendar days. Sales are signed so a declining price is a positive result for the seller. Not investment advice.